Literature DB >> 7296587

Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding.

J S Karliner, C Alabaster, H Stephens, P Barnes, C Dollery.   

Abstract

To assess the possible relation between catecholamine responses and adrenoceptor affinity and density, we compared the effect of noradrenaline, isoprenaline and ouabain on the right ventricular muscle strips from normal and cardiomyopathic hamsters with alpha 1- and beta-adrenoceptor characteristics assessed by radioligand binding methods. At concentrations of 1.28, 2.56, 5.0 and 10 x 10 (-6) mol . litre (-1) noradrenaline raised isometric tension by 27 +/- 4, 39 +/- 5, 52 +/- 5 and 61 +/-6% in normal animals (n = 6). Corresponding increase of 65 +/- 8, 92 +/- 8, 109 +/- 9 and 115 +/- 10% occurred in cardiomyopathic hamsters (n=11, all P less than 0.02). The responses to isoprenaline (Emax =82%) and ouabain did not differ between the two groups of hamsters. [3H]-prazosin, a new radioligand, and [-3H]-dihydroalprenolol were used to assess alpha 1- and beta-adrenoceptors in cardiac membranes. By Scatchard analysis, the KD values for both ligands did not differ between normal and cardiomyopathic hamsters, but the maximum number of binding sites was higher in the myopathic group: 5.5 vs 3.9 fmol . mg [-1] protein for [3H]-prazosin and 27 vs 20 fmol . mg [-1] protein for [-3H]-dihydroalprenolol (both P less than 0.05). Histochemically, oxidative and glycolytic activity were normal but lysosomal acid phosphatase was high. Possible explanations for the raise response to noradrenaline in cardiomyopathic hamster include and increased concentration of noradrenaline in the synaptic cleft due to defective neuronal uptake and / or stimulation of an augmented population of alpha 1-(postsynaptic) adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296587     DOI: 10.1093/cvr/15.5.296

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Stimulatory guanine nucleotide-binding protein and adenylate cyclase activities in Bio 14.6 cardiomyopathic hamsters at the hypertrophic stage.

Authors:  T Ikegaya; A Kobayashi; R B Hong; H Masuda; M Kaneko; Y Noboru
Journal:  Mol Cell Biochem       Date:  1992-03-04       Impact factor: 3.396

2.  Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure.

Authors:  C Forster; J S Main; P W Armstrong
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

3.  Modification of aortic contractility in the cardiomyopathic hamster.

Authors:  E C Dumont; C Lambert; D Lamontagne
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters.

Authors:  R Sethi; N Bector; N Takeda; M Nagano; G Jasmin; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

5.  Cardiac ultrastructural abnormalities in Syrian hamsters with spontaneous cardiomyopathy or subjected to cardiac overloads.

Authors:  J Perennec; M Willemin; P Pocholle; P Y Hatt; B Crozatier
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

6.  Reduction of ventricular M2 muscarinic receptors in cardiomyopathic hamster (CHF 147) at the necrotic stage of the myopathy.

Authors:  M Wilkinson; M Horackova; A Giles
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

7.  Verapamil induced reduction of the myocardial beta-adrenoceptor density in BIO 14.6 cardiomyopathic Syrian hamsters.

Authors:  A Kobayashi; T Nishiyama; T Ikegaya; M Kaneko; N Yamazaki
Journal:  Mol Cell Biochem       Date:  1993-04-07       Impact factor: 3.396

Review 8.  Changes in adrenergic receptors during the development of heart failure.

Authors:  N S Dhalla; I M Dixon; S Suzuki; M Kaneko; A Kobayashi; R E Beamish
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

9.  Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.

Authors:  Oleg E Osadchii; Angela J Woodiwiss; Dawn Deftereos; Gavin R Norton
Journal:  Pflugers Arch       Date:  2007-06-09       Impact factor: 3.657

10.  Beta-adrenoceptor mediated signal transduction in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters.

Authors:  D Kaura; N Takeda; R Sethi; X Wang; M Nagano; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.